Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients, Angela C Webster, Vincent WS Lee, Jeremy R Chapman and Jonathan C Craig. DOI: 10.1002/14651858.CD004290.pub2
Complete the form below and we will send an e-mail message containing a link to the selected mrwArticle on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.